Clinical trials - Press Releases

Date	Title	Company
06-Jan-2021	Cellnutrition Health Introduces Promising New Vaccine and Immunotherapy	Cellnutrition
05-Jan-2021	Phase 2b clinical trial of XF-73 completes patient recruitment	Destiny Pharma plc
04-Jan-2021	Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London	Panthera Biopartners
04-Jan-2021	Stefan Przyborski from University of Durham invites you to join 3D Cell Culture Virtual Conference	SMi Group
24-Dec-2020	Innovative drug, Carrimycin, Receives FDA Approval for International, Multi-country Phase III Clinical Trial for the treatment of severe COVID-19 in hospitalized patients	Shenyang Tonglian Group Co., Ltd
23-Dec-2020	Amryt Granted Orphan Drug Designation by the FDA for AP103	Amryt
23-Dec-2020	CURRANZ AWARDED TWO ACCOLADES AT THE EUROPEAN SPECIALIST SPORTS NUTRITION ALLIANCE AWARDS 2020	CurraNZ
23-Dec-2020	UPM Biochemicals grows lignin business with new Domtar supply agreement	UPM Biochemicals
22-Dec-2020	VFMCRP and ChemoCentryx provide topline results from ACCOLADE trial of avacopan in C3 glomerulopathy including improved estimated glomerular filtration rate (eGFR)	Vifor Fresenius Medical Care Renal Pharma (VFMCRP)
22-Dec-2020	Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study	Bone Therapeutics
22-Dec-2020	Chi-Med to Present at the 39th Annual JP Morgan Healthcare Conference	Chi-Med
22-Dec-2020	Update on the recently acquired NTCD-M3 biotherapeutic clinical programme for prevention of recurrence of C. difficile infections	Destiny Pharma plc
22-Dec-2020	GLOBAL TEAM OF SCIENTISTS UNITE TO ASSESS ROLE OF T CELLS IN THE BATTLE AGAINST COVID-19 AND EVALUATE STEPS IN MANAGING AND PROTECTING AGAINST FUTURE INFECTIOUS DISEASE	Global T cell Expert Consortium
22-Dec-2020	Bone Therapeutics finalise le recrutement et le traitement des patients dans son étude pivot de Phase III évaluant le JTA-004 dans l’arthrose du genou	Bone Therapeutics
22-Dec-2020	VFMCRP and ChemoCentryx Provide Topline Results From ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)	Vifor Pharma Group
22-Dec-2020	UKCPA Meets Demand For Critical Care Training With New Online	The UK Clinical Pharmacy Association (UKCPA)
22-Dec-2020	Transgene and BioInvent receive CTA approval for Phase 1/2a trial of oncolytic virus BT-001 in solid tumors	Transgene
22-Dec-2020	Janssen Announces European Commission Authorisation of the First Complete Long-Acting Injectable HIV Treatment in Europe	Janssen Pharmaceutical Companies of Johnson & Johnson
22-Dec-2020	GLOBAL HEALTHCARE SECTOR INVESTS OVER £1.3 MILLION TO BOOST INTERNAL COMMUNICATIONS	St George’s University Hospitals NHS Foundation Trust
22-Dec-2020	Exclusive Interview with Mark DePristo, BigHat BioScience speaker at AI in Drug Discovery 2021	SMi Group